“There is no valid scientific data to show that thermographic devices, when used on their own or with another diagnostic test, are an effective screening tool for any medical condition, including the early detection of breast cancer or other diseases and conditions,” the FDA wrote. “The agency stresses that mammography is the only screening method proven to reduce deaths from breast cancer through early detection.”  

CT angiography (CTA) and transcranial Doppler (TCD) fall short in detecting cerebral vasospasm (CVS) and predicting delayed cerebral ischemia (DCI) in patients with subarachnoid hemorrhage (SAH), reported authors of a recent study published in the inaugural edition of Critical Care Explorations.

Researchers used T2 mapping taken from weekly cardiac MRIs to help identify cardiotoxicity at an early stage, according to results of a pig study published Feb. 18 in the Journal of the American College of Cardiology. The findings could help cancer patients at risk of chemo-induced heart failure.

T2 mapping derived from weekly cardiac MRIs helped researchers identify cardiotoxicity at an early and reversible stage, a finding which may have implications for cancer patients at risk of chemotherapy-induced heart failure.

The Department of Energy’s National Nuclear Security Administration (NNSA) has chosen four U.S. companies to begin negotiations with in an effort to produce Molybdenum-99 (Mo-99) without the use of highly enriched uranium.

A novel PET/CT imaging agent—18F-GP1—produced a high-quality image and yielded a high detection rate for diagnosing acute venous thromboembolism (VTE), reported researchers of a study featured in the February issue of The Journal of Nuclear Medicine.

Stereotactic ablative body radiation therapy (SABR) nearly doubled the overall survival of patients with inoperable stage I lung cancer compared to standard radiotherapy, according to results of a multi-center phase III trial published in the Lancet Oncology.

The FDA has approved nerve stimulation for treatment of episodic and chronic cluster headaches and acute migraines. The findings, detailed in a study published online Feb. 13 in PLOS ONE, could help personalize treatment for PTSD, which according to the National Institute of Mental Health impacts roughly 3.6 percent of U.S. adults per year.